Literature DB >> 31742022

Management of Head and Neck Hemangiomas in Adults: Oral Propranolol Versus Oral Itraconazole in Conjugation with Injection Sodium Tetra Decyl Sulphate.

Siddharth Panditray1, Sauvagini Acharya1, Nilamadhab Prusty1, Subha Saumya Dany2.   

Abstract

Management of head and neck hemangiomas with oral propranolol versus oral itraconazole in conjugation with injection sodium tetra decyl sulphate. This prospective parallel clinical trial was done to check for the effectiveness of oral propranolol and oral itraconazole when used in conjugation with inj. sodium tetra decyl sulphate in treatment of head and neck haemangiomas in adult patients visiting department of ENT and head and neck surgery, VIMSAR, Burla. All the patients visiting the department with hemangioma (diagnosed clinically and by FNAC) were considered and only those who gave written informed consent and were according to our inclusion and exclusion criteria were included into the study as subjects. Dimension (length, width and hemi-circumference) of the haemangiomas were measured using disposable paper taper measures. Depth of the hemangioma was calculated based on formula and using that volume was calculated both at baseline and after 8 weeks of drug administration. Data so collected was entered into Microsoft Office Excel 2013 and statistical analysis was performed using SPSS Version 20.0. Descriptive statistics was calculated and student's t test (paired and unpaired) was used to compare within the group (before and after) and between the groups respectively. Statistical significance was set at p ≤ 0.05. Both the groups showed statistically significant volume reduction in the lesions [p < 0.018 (propranolo + sodium tetra decyl sulphate), p < 0.025 (itraconazole + sodium tetra decyl sulphate)]. The mean decrease in volume in propranolol group was 91.92% and that in itraconazole group was 88.97%. There was no statistical difference between the final outcome of both the groups (p < 0.766) but 3 patients on propranolol had complete resolution while 1 patient on itraconazole had complete resolution of the lesion. Oral propranolol and itraconazole are both effective and safe in hemangioma in adults. The combination with inj. sodium tetra decyl sulphate has a (1) favorable impact on decreasing the overall duration of treatment. (2) Aiding in complete resolution of lesions (especially < 3 cm). Propranolol has an edge over itraconazole (more no of tumors had complete resolution). © Association of Otolaryngologists of India 2018.

Entities:  

Keywords:  Hemangiomas; Itraconazole; Propranolol; Sclerotherapy

Year:  2018        PMID: 31742022      PMCID: PMC6848284          DOI: 10.1007/s12070-018-1410-8

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  36 in total

1.  Atenolol versus propranolol for the treatment of infantile hemangiomas: a randomized controlled study.

Authors:  Alvaro Ábarzúa-Araya; Cristián P Navarrete-Dechent; Felipe Heusser; Javiera Retamal; María Soledad Zegpi-Trueba
Journal:  J Am Acad Dermatol       Date:  2014-03-20       Impact factor: 11.527

2.  Propranolol for severe hemangiomas of infancy.

Authors:  Christine Léauté-Labrèze; Eric Dumas de la Roque; Thomas Hubiche; Franck Boralevi; Jean-Benoît Thambo; Alain Taïeb
Journal:  N Engl J Med       Date:  2008-06-12       Impact factor: 91.245

3.  Itraconazole, a commonly used antifungal that inhibits Hedgehog pathway activity and cancer growth.

Authors:  James Kim; Jean Y Tang; Ruoyu Gong; Jynho Kim; John J Lee; Karl V Clemons; Curtis R Chong; Kris S Chang; Mark Fereshteh; Dale Gardner; Tannishtha Reya; Jun O Liu; Ervin H Epstein; David A Stevens; Philip A Beachy
Journal:  Cancer Cell       Date:  2010-04-13       Impact factor: 31.743

4.  Intralesional Sclerotherapy - A Novel Approach for The Treatment of Intraoral Haemangiomas.

Authors:  G Siva Prasad Reddy; G Venkateshwara Reddy; K Sravan Kumar Reddy; B Srilatha Priyadarshini; P Karuna Sree
Journal:  J Clin Diagn Res       Date:  2016-01-01

5.  Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study.

Authors:  Nhung T C Ho; Perla Lansang; Elena Pope
Journal:  J Am Acad Dermatol       Date:  2007-01       Impact factor: 11.527

6.  Combination of propranolol and sclerotherapy for treatment of infantile parotid hemangiomas.

Authors:  Xiaorong Ma; Mengling Chang; Tianxiang Ouyang; Daili Xu; Miao Xu; Jingwen Ke; Jun Lin; Jun Liu; Jie Yu; Huiping Chen
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 7.  Diagnosis and management of hemangiomas and vascular malformations of the head and neck.

Authors:  L M Buckmiller; G T Richter; J Y Suen
Journal:  Oral Dis       Date:  2010-03-09       Impact factor: 3.511

Review 8.  Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses.

Authors:  S M Grant; S P Clissold
Journal:  Drugs       Date:  1989-03       Impact factor: 9.546

9.  Treatment of massive or life-threatening hemangiomas with recombinant alpha(2a)-interferon.

Authors:  N M Bauman; D K Burke; R J Smith
Journal:  Otolaryngol Head Neck Surg       Date:  1997-07       Impact factor: 5.591

10.  Sclerotherapy for the treatment of infantile hemangiomas.

Authors:  Chander Grover; Ananta Khurana; Sambit N Bhattacharya
Journal:  J Cutan Aesthet Surg       Date:  2012-07
View more
  1 in total

1.  Itraconazole as a new pharmacotherapy method in haemangiomas.

Authors:  Przemysław Gałązka; Kamil Leis; Ewelina Mazur; Laura Nowowiejska
Journal:  Postepy Dermatol Alergol       Date:  2022-01-07       Impact factor: 1.837

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.